fda approves first oral glp-1 obesity drug august 21 2025 US Wegovy Pill for Weight Loss Wegovy Pill FDA Approved: What
Description
Semaglutide for Weight Loss What You Need to Know
Kavianipour, M
GLP-1: glucagon-like peptide 1 receptor
Wegovy (semaglutide 2.4mg weekly) In the STEP 1 trial, adults on Wegovy lost an average of 14.9% of their body weight over 68 weeks
Absorbance was measured at 450 nm using a Sunrise Absorbance Microplate Reader (Tecan Group Ltd.)
Gardiner SM, March JE, Kemp PA, Bennett T
